The Resource High-containment biosafety laboratories : preliminary observations on the oversight of the proliferation of BSL-3 and BSL-4 laboratories in the United States : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Keith Rhodes

High-containment biosafety laboratories : preliminary observations on the oversight of the proliferation of BSL-3 and BSL-4 laboratories in the United States : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Keith Rhodes

Label
High-containment biosafety laboratories : preliminary observations on the oversight of the proliferation of BSL-3 and BSL-4 laboratories in the United States : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives
Title
High-containment biosafety laboratories
Title remainder
preliminary observations on the oversight of the proliferation of BSL-3 and BSL-4 laboratories in the United States : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives
Statement of responsibility
statement of Keith Rhodes
Title variation
  • High containment biosafety laboratories
  • Preliminary observations on the oversight of the proliferation of BSL-3 and BSL-4 laboratories in the United States
Title variation remainder
preliminary observations on the oversight of the proliferation of BSL-3 and BSL-4 laboratories in the United States
Creator
Contributor
Subject
Language
eng
Summary
In response to the global spread of emerging infectious diseases and the threat of bioterrorism, high-containment biosafety laboratories (BSL)--specifically biosafety level (BSL)-3 and BSL-4--have been proliferating in the United States. These labs--classified by the type of agents used and the risk posed to personnel, the environment, and the community--often contain the most dangerous infectious disease agents, such as Ebola, smallpox, and avian influenza. This testimony addresses (1) the extent to which there has been a proliferation of BSL-3 and BSL-4 labs, (2) federal agencies' responsibility for tracking this proliferation and determining the associated risks, and (3) the lessons that can be learned from recent incidents at three high-containment biosafety labs. To address these objectives, GAO asked 12 federal agencies involved with high-containment labs about their missions and whether they tracked the number of labs overall. GAO also reviewed documents from these agencies, such as pertinent legislation, regulation, and guidance. Finally, GAO interviewed academic experts in microbiological research
Member of
Cataloging source
EJB
http://library.link/vocab/creatorName
Rhodes, Keith A
Government publication
federal national government publication
Illustrations
  • illustrations
  • maps
Index
no index present
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://library.link/vocab/relatedWorkOrContributorName
  • United States
  • United States
Series statement
Testimony
Series volume
GAO-08-108 T
http://library.link/vocab/subjectName
  • Microbiological laboratories
  • Medical laboratories
Label
High-containment biosafety laboratories : preliminary observations on the oversight of the proliferation of BSL-3 and BSL-4 laboratories in the United States : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Keith Rhodes
Link
Instantiates
Publication
Note
  • Title from title screen (viewed on Oct. 5, 2007)
  • "For release on delivery...October 4, 2007."
  • Paper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
mixed
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Control code
17578315
Dimensions
unknown
Extent
35 pages
Form of item
electronic
Media category
computer
Media MARC source
rdamedia
Media type code
c
Other physical details
digital, PDF file.
Specific material designation
remote
System details
Mode of access: Internet. Address as of 10/5/07: http://www.gao.gov/new.items/d08108t.pdf ; current access available via PURL
Label
High-containment biosafety laboratories : preliminary observations on the oversight of the proliferation of BSL-3 and BSL-4 laboratories in the United States : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Keith Rhodes
Link
Publication
Note
  • Title from title screen (viewed on Oct. 5, 2007)
  • "For release on delivery...October 4, 2007."
  • Paper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
mixed
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Control code
17578315
Dimensions
unknown
Extent
35 pages
Form of item
electronic
Media category
computer
Media MARC source
rdamedia
Media type code
c
Other physical details
digital, PDF file.
Specific material designation
remote
System details
Mode of access: Internet. Address as of 10/5/07: http://www.gao.gov/new.items/d08108t.pdf ; current access available via PURL

Library Locations

    • Indiana State LibraryBorrow it
      315 W. Ohio St., Indianapolis, IN, 46202, US
      39.77004 -86.164015

Library Links

Processing Feedback ...